Top of page
Lawyers

Dana Lueck-Mammen

Lawyers

Filters

Turning Point Therapeutics $460 million stock offering
Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…
Back to top